Effervescent enteric coated L-dopa formulation and method of usi

Details Effervescent enteric coated L-dopa formulation and method of usi Effervescent enteric coated L-dopa formulation and method of usi

1975-04-10

1976-06-01

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

Polymer from ethylenic monomers only

424 44, 424177, A61K 922, A61K 946, A61K 930

Patent

active

039610411

ABSTRACT:
Therapeutic levels of L-DOPA are achieved by orally administering a pharmaceutical effervescent-enteric coated tablet comprising:

REFERENCES:
patent: 3131123 (1964-04-01), Masquelier
patent: 3891696 (1975-06-01), Bodor et al.
Sandler, M. et al. Lancet Feb. 16, 1974 pp. 238-240 Variation of Levodopa Metabolism with Gastrointestinal Absorption Site.
Eckstein, B. et al. Lancet Feb. 24, 1973 pp. 431-432 Sustained-Release Levodopa in Parkinsonism.
Curzon, G. et al. Lancet Apr. 7, 1973 p. 781 Sustained-Release Levodopa in Parkinsonism.
Voller, G. W. et al. Acta Neurol Scand 50(3): 391-393 (1974) Efficacy of and Possible Differences in Tolerance to L-DOPA Tablets with Different Rates of Release of the Active Substance.

Affiliated with

Also associated with

Rating

Effervescent enteric coated L-dopa formulation and method of usi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Effervescent enteric coated L-dopa formulation and method of usi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Effervescent enteric coated L-dopa formulation and method of usi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2403437